{"version":"1.0","type":"rich","width":"560px","height":"140px","title":"Folge 295: Donanemab, Cefixim, der OTC-Markt &#038; Impfungen","url":"https:\/\/podcast.ptaheute.de\/2026\/05\/04\/folge-295-donanemab-cefixim-der-otc-markt-impfungen\/","author_name":"PTAheute Podcast - Ein Podcast von PTAheute.de","author_url":"https:\/\/podcast.ptaheute.de","thumbnail_url":"http:\/\/podcast.ptaheute.de\/wp-content\/uploads\/2023\/06\/PTAheute-Podcast.png","html":"<iframe width=\"560px\" height=\"140px\" src=\"https:\/\/podcast.ptaheute.de\/2026\/05\/04\/folge-295-donanemab-cefixim-der-otc-markt-impfungen\/?standalonePlayer\"><\/iframe>"}